Your Client Rank:
Loading...
99
Updated 27-Jul-2024
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Lilly | 19.5% | 0.5% | -8.4% | -12.4% | 17.7% | -6.5% | 42.1% | 42.3% |
| Novo | 16.5% | 0.1% | -3.6% | 0.6% | 1.5% | 0.4% | 18.0% | 18.9% |
| Daiichi | 12.3% | 2.2% | 1.6% | -2.0% | 9.7% | 4.1% | 19.7% | 20.2% |
| Vertex | 8.8% | 0.7% | 1.8% | -6.3% | 0.8% | 1.0% | 10.2% | 9.8% |
| Regeneron | 7.7% | 0.2% | -0.7% | -0.6% | 3.3% | 14.2% | 9.7% | 9.6% |
| Astra | 7.6% | 0.0% | -3.5% | -0.9% | 4.3% | 3.5% | 10.7% | 10.6% |
| Eisai | 6.6% | -0.9% | -1.6% | -3.8% | 12.2% | -7.6% | 20.4% | 20.9% |
| Merck | 5.9% | 1.2% | -2.4% | -17.0% | 34.7% | -15.5% | 52.1% | 52.9% |
| Sanofi | 5.5% | 1.0% | -3.6% | -1.4% | 5.0% | 2.5% | 7.0% | 7.3% |
| AbbVie | 5.4% | 0.2% | -2.9% | -1.8% | 2.1% | 1.7% | 7.8% | 8.0% |
| Amgen | 4.8% | -0.2% | 0.3% | 1.2% | -1.1% | -0.7% | 3.7% | 4.1% |
| JnJ | 4.2% | -0.1% | -1.0% | -1.2% | 0.9% | 3.0% | 3.5% | 5.5% |
| Glaxo | 4.1% | 0.4% | -1.5% | -0.1% | 3.2% | 2.8% | 6.6% | 6.2% |
| Novartis | 3.7% | 0.1% | -3.0% | -0.4% | 2.6% | 1.6% | 6.4% | 7.7% |
| Roche | 3.7% | 0.2% | -1.0% | -0.4% | 1.6% | 9.9% | 4.5% | 4.3% |
| Teva | 3.1% | 1.3% | -2.2% | -0.6% | 2.1% | 4.2% | 6.9% | 6.1% |
| Chugai | 2.4% | 2.6% | 1.8% | 1.2% | 3.2% | 0.2% | 5.5% | 5.5% |
| Gilead | 2.1% | -0.1% | -1.9% | -2.7% | 2.3% | 5.5% | 3.5% | 4.0% |
| Biogen | 2.0% | 1.8% | -1.0% | -3.6% | 6.8% | 1.2% | 9.8% | 9.9% |
| Lundbeck | 1.9% | 1.2% | -3.3% | 2.4% | 5.2% | -0.6% | 10.3% | 2.9% |
| Takeda | 1.4% | 0.3% | -0.4% | 0.5% | 24.6% | | 4.7% | 25.4% |
| Shionogi | 0.9% | -0.5% | -2.5% | 2.3% | 0.3% | 0.6% | 0.5% | 1.3% |
| Bayer | 0.8% | 0.2% | 0.8% | 3.3% | 1.0% | | -2.3% | -1.2% |
| Astellas | 0.8% | -0.6% | -5.5% | 0.6% | 13.7% | 9.5% | 12.5% | 13.3% |
| Pfizer | 0.7% | 4.3% | -1.6% | 0.9% | 14.9% | 11.4% | 9.4% | 8.3% |
| Bristol | -1.8% | -0.3% | 1.5% | -0.4% | -0.4% | 3.3% | -4.9% | -4.0% |
| Neurocrine | | | | | | | | |
| EU Major | 5.8% | 0.6% | -2.3% | -0.2% | 3.6% | 1.4% | 8.3% | 6.5% |
| Other EU | 1.9% | 1.2% | -3.3% | 2.4% | 5.2% | -0.6% | 10.3% | 2.9% |
| US Major | 5.5% | 1.1% | -2.7% | -6.8% | 8.6% | 0.0% | 13.4% | 18.1% |
| US Big Biotech | 4.7% | 0.3% | -1.1% | -1.8% | 1.5% | 2.5% | 6.2% | 8.3% |
| Other US | 3.1% | 1.3% | -2.2% | -0.6% | 2.1% | 4.2% | 6.9% | 6.1% |
| Japanese | 3.9% | 0.8% | -0.5% | 0.0% | 10.6% | 11.8% | 8.1% | 10.3% |
